Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Finkelstein

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|January 9, 2020
Health Care Hotspotting - A Randomized, Controlled TrialAmy Finkelstein, Annetta Zhou, Sarah Taubman, et al.
The American Economic Review|October 28, 2016
Health Care Exceptionalism? Performance and Allocation in the US Health Care SectorAmitabh Chandra, Amy Finkelstein, Adam Sacarny, et al.
American Economic Journal. Applied Economics|July 19, 2016
Beyond Statistics: The Economic Content of Risk ScoresLiran Einav, Amy Finkelstein, Raymond Kluender, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2020
Randomized trial shows healthcare payment reform has equal-sized spillover effects on patients not targeted by reformLiran Einav, Amy Finkelstein, Yunan Ji, et al.
The Journal of Political Economy|April 30, 2021
The Value of Medicaid: Interpreting Results from the Oregon Health Insurance ExperimentAmy Finkelstein, Nathaniel Hendren, Erzo F P Luttmer
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2020
Initial economic damage from the COVID-19 pandemic in the United States is more widespread across ages and geographies than initial mortality impactsMaria Polyakova, Geoffrey Kocks, Victoria Udalova, et al.
The New England Journal of Medicine|February 16, 2017
Adjusting Risk Adjustment - Accounting for Variation in Diagnostic IntensityAmy Finkelstein, Matthew Gentzkow, Peter Hull, et al.
Science (New York, N.Y.)|June 30, 2018
Predictive modeling of U.S. health care spending in late lifeLiran Einav, Amy Finkelstein, Sendhil Mullainathan, et al.
JAMA Health Forum|October 7, 2022
Financial Incentives to Facilities and Clinicians Treating Patients With End-stage Kidney Disease and Use of Home Dialysis: A Randomized Clinical TrialYunan Ji, Liran Einav, Neale Mahoney, et al.
The Review of Economics and Statistics|June 4, 2026
Heterogeneity in Damages from A PandemicAmy Finkelstein, Geoffrey Kocks, Maria Polyakova, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|January 9, 2020
Health Care Hotspotting - A Randomized, Controlled TrialAmy Finkelstein, Annetta Zhou, Sarah Taubman, et al.
The American Economic Review|October 28, 2016
Health Care Exceptionalism? Performance and Allocation in the US Health Care SectorAmitabh Chandra, Amy Finkelstein, Adam Sacarny, et al.
American Economic Journal. Applied Economics|July 19, 2016
Beyond Statistics: The Economic Content of Risk ScoresLiran Einav, Amy Finkelstein, Raymond Kluender, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2020
Randomized trial shows healthcare payment reform has equal-sized spillover effects on patients not targeted by reformLiran Einav, Amy Finkelstein, Yunan Ji, et al.
The Journal of Political Economy|April 30, 2021
The Value of Medicaid: Interpreting Results from the Oregon Health Insurance ExperimentAmy Finkelstein, Nathaniel Hendren, Erzo F P Luttmer
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2020
Initial economic damage from the COVID-19 pandemic in the United States is more widespread across ages and geographies than initial mortality impactsMaria Polyakova, Geoffrey Kocks, Victoria Udalova, et al.
The New England Journal of Medicine|February 16, 2017
Adjusting Risk Adjustment - Accounting for Variation in Diagnostic IntensityAmy Finkelstein, Matthew Gentzkow, Peter Hull, et al.
Science (New York, N.Y.)|June 30, 2018
Predictive modeling of U.S. health care spending in late lifeLiran Einav, Amy Finkelstein, Sendhil Mullainathan, et al.
JAMA Health Forum|October 7, 2022
Financial Incentives to Facilities and Clinicians Treating Patients With End-stage Kidney Disease and Use of Home Dialysis: A Randomized Clinical TrialYunan Ji, Liran Einav, Neale Mahoney, et al.
The Review of Economics and Statistics|June 4, 2026
Heterogeneity in Damages from A PandemicAmy Finkelstein, Geoffrey Kocks, Maria Polyakova, et al.
Pageof 7